Education
About Us
Working with TipRanks
Follow Us
Guided Therapeutics (GTHP)
:GTHP
GTHP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.30
Previous CloseN/A
Volume813.00
Average Volume (3M)11.62K
Market Cap
$22.09M
Enterprise Value$9.70M
Total Cash (Recent Filing)$115.00K
Total Debt (Recent Filing)$2.01M
Price to Earnings (P/E)―
Beta1.60
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding78,910,180
10 Day Avg. Volume22,570
30 Day Avg. Volume11,616
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-3.38
Price to Sales (P/S)0.00
P/FCF Ratio-6.46
Enterprise Value/Market Cap0.44
Enterprise Value/Revenue131.10
Enterprise Value/Gross Profit461.98
Enterprise Value/Ebitda-1.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
33.78% Insiders
―
Mutual Funds
― Other Institutional Investors
66.22% Public Companies and
Individual Investors
GTHP FAQ
What was Guided Therapeutics’s price range in the past 12 months?
Guided Therapeutics lowest stock price was $0.06 and its highest was $0.30 in the past 12 months.
What is Guided Therapeutics’s market cap?
Guided Therapeutics’s market cap is $22.09M.
When is Guided Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Guided Therapeutics’s earnings last quarter?
Guided Therapeutics released its earnings results on Aug 15, 2023. The company reported -$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.032.
Is Guided Therapeutics overvalued?
According to Wall Street analysts Guided Therapeutics’s price is currently Overvalued.
Does Guided Therapeutics pay dividends?
Guided Therapeutics does not currently pay dividends.
What is Guided Therapeutics’s EPS estimate?
Guided Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guided Therapeutics have?
Guided Therapeutics has 78,910,180 shares outstanding.
What happened to Guided Therapeutics’s price movement after its last earnings report?
Guided Therapeutics reported an EPS of -$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Guided Therapeutics?
Currently, no hedge funds are holding shares in GTHP
Company Description
Guided Therapeutics
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Technical Analysis
Neurometrix
―
Aethlon Medical
―
Movano
―
Tenon Medical, Inc.
―
DIH Holdings US, Inc Class A
―